Pharming Group N.V. generated $376.1M in revenue in fiscal year 2025. This represents an increase of 26.6% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025.
Annual figures, oldest first. Point at a bar to read its period.
PHAR Revenue by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Pharming Group N.V. financials
Frequently Asked Questions
Pharming Group N.V. generated $376.1M in revenue in fiscal year 2025.
Pharming Group N.V. (PHAR) revenue rose by 26.6% year over year, from $297.2M to $376.1M in fiscal year 2025.
Across the 7 fiscal years this page covers, Pharming Group N.V. (PHAR) revenue went from $189.4M in fiscal year 2019 to $376.1M in fiscal year 2025.
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Pharming Group N.V. (PHAR) reported on that line in every period on record.